Viral expression vectors
US6656726B1 · kind B1 · utility
3Cited by
10References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2000 |
| Grant date | Dec 2, 2003 |
| Priority date | — |
| Expiry date | May 4, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/00043
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides nucleic acid sequences having an altered viral movement protein and 126/183 kDa replicase proteins further characterized in its ability to stabilize a transgene contained in a virus that expresses the altered movement protein. The present invention also provides viral vectors expressing the altered movement protein, cells transformed with the vectors, and host plants infected by the viral vectors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.